MinervaX's Seed VC Round

MinervaX raised a round of funding on January 08, 2014.

MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity.…

Articles about MinervaX's Seed VC Round: